31 Mar 2021
Assets353.93
Total Income609.95
Profit After Tax11.01
NET Worth64.54
Reserves and Surplus60.80
Total Borrowing159.19
Open 29th Feb 2024 · Close 4th Mar 2024 · Listing 7th Mar 2024
The shares listed at ₹40.00, a 42.86% move from the issue price. Mukka Proteins is a Mainboard IPO with an issue size of ₹224.00 crore, proposed for listing on BSE, NSE. The offer opens on 29th Feb 2024 and closes on 4th Mar 2024. The issue structure includes a fresh issue of ₹224.00 crore. The current listing schedule points to 7th Mar 2024.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 535 | ₹14,980 |
| Object | Amount |
|---|---|
| Funding working capital requirements of the Company | ₹120.00 Cr |
| Investment in our Associate, viz. Ento Proteins Private Limited, for funding its working capital requirements; and | ₹10.00 Cr |
| General Corporate Purpose | ₹55.81 Cr |
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
| Price to Book Value |
| Expense | Amount |
|---|---|
| Fees payable to the BRLM | ₹1.20 Cr |
| Commission/processing fee for SCSBs, Sponsor Bank(s) and Bankers to the Issue and fee payable to the Sponsor Bank for Bids made by RIBs. Brokerage, underwriting commission and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, CRTAs and CDP(1)(2)(3)(4) | ₹0.40 Cr |
| Advertising and marketing expenses | ₹1.40 Cr |
| Fee payable to auditors, consultants, Advisors to the Company and market research firms, commissions (including underwriting commission, brokerage and selling commission). | ₹32.30 Cr |
| Listing fees, SEBI, BSE and NSE processing fees, book building software fees and other regulatory expenses; Printing and distribution of stationery; Fees payable to the Registrar to the Issue; Fees payable to legal counsels; Monitoring Agency; and Miscellaneous. | ₹2.89 Cr |